Biomarker ID | 1595 |
PMID | 26254378 |
Year | 2015 |
Biomarker | Prostate Specific Antigen (PSA) |
Biomarker Basis | Concentration Based (μg/L) |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in PCa [BPH: 7.2 (1.8-19.8); PCa: 7.7 (1.0-19.4)] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathway include: Collagen chain trimerization; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Signaling by Rho GTPases; Adhesion; Pathways in cancer |
Experiment | Prostate Cancer Vs Benign prostatic hyperplasia |
Type of Biomarker | Diagnostic |
Cohort | 150 patients with Benign Prostatic Hyperplasia and 113 with Prostate cancer were selected for the study |
Senstivity | Cut off 4μg/L: 11%; Cut off 10 μg/L: 79% |
Specificity | Cut off 4μg/L: 96%; Cut off 10 μg/L: 23% |
AUC | 0.57855 |
Accuracy | NA |
Level Of Significance | p = 0.0407 |
Method Used | Chemiluminescence |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |